Aman Jain
Partner
DelhiPractice Area
Sectors
I am driven to help clients efficiently navigate the regulatory landscape and finding practical solutions in line with their commercial interests.
With 10 years of experience, Aman specialises in Corporate/Mergers & Acquisitions, Private Equity and general corporate advisory matters. He regularly advises clients on strategic transactions with a particular focus on listed company M&A along with private equity/venture capital investments in a variety of sectors including fintech and digital, pharmaceuticals, healthcare, foods and agriculture, e-commerce, etc. His experience also includes advising on SEBI regulations, foreign investment into India and outward transactions, including transaction structuring.
WORK HIGHLIGHTS
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
-
End-to-end advise on divestment of ‘Horlicks’ and other consumer brands and GlaxoSmithKline Consumer Healthcare Limited’s merger with Hindustan Unilever Limited including structuring advice, and further stake sale by GlaxoSmithKline plc on its sale of approximately 5.69% stake of Hindustan Unilever Limited on the floor of the stock exchange
-
Separation of group’s consumer healthcare and pharmaceuticals business in India as part of the global restructuring
-
Investment in Ascend Bizcap
-
Divestment of its apparel business in a cash plus share swap deal to Gokaldas Exports Limited
-
Investment in LT Foods Limited
RECENT RECOGNITION
2026
Legal 500 Asia Pacific
Recommended for Private Equity Funds (including Venture Capital)
RECENT RECOGNITION
Legal 500 Asia Pacific
Recommended for Private Equity Funds (including Venture Capital)